GLN-BILASTINE
Identification of Gln-Bilastine
| No description |
Google image searchProduct monograph
Active ingredient
bilastine, 20 MG
DIN: 02544369
Dosage form(s): TABLET
Route(s) of administration: ORAL
Schedule: Prescription
Company: GLENMARK PHARMACEUTICALS CANADA INC.
Date: 22-OCT-2024
ATC:
- R06 — ANTIHISTAMINES FOR SYSTEMIC USE (ATC, ATC/DDD, )
- R06A — ANTIHISTAMINES FOR SYSTEMIC USE (ATC, ATC/DDD)
- R06AX — Other antihistamines for systemic use (ATC, ATC/DDD)
- R06AX29 — BILASTINE (ATC/DDD)
